Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Solid Phase Peptide Synthesis (SPPS). These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel solid-phase synthesis method for Apraglutide improves yield and purity. Reduces hydrophobic aggregation issues for reliable pharmaceutical intermediate supply.
Patent CN101357937A details an efficient Fmoc-based SPPS route for Atosiban, offering high purity and reduced waste for pharmaceutical manufacturing.
Advanced preparation of Desmopressin Acetate via solid-phase synthesis and liquid-phase oxidation. High purity, scalable process for reliable pharmaceutical intermediates supply.
Patent CN103554226B details all-solid-phase synthesis for alpha-conotoxin MI. Enhances purity and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN101712716B details a solid-phase iodine oxidation method for Vapreotide, improving yield and purity while simplifying manufacturing for reliable supply chains.
Patent CN101693738B reveals a green solid-phase oxidation method for Terlipressin, offering higher yields and reduced waste for reliable API manufacturing.
Advanced solid phase synthesis of Octreotide using DHP HM Resin. Eliminates racemization risks and ensures high purity for pharmaceutical manufacturing.
Patent CN1260250C details a safer TFA-based solid phase synthesis for Thymopentin. Discover cost reduction in peptide manufacturing and enhanced supply chain reliability.
Advanced solid-phase synthesis of TP-5 using Fmoc/Wang strategy eliminates hazardous HF, offering high purity and scalable production for pharmaceutical manufacturers.
Patent CN114195881B reveals a novel ionic liquid method for high-purity Sermorelin Acetate production, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN112062835B details a novel solid-phase method for Bivalirudin, achieving >99.8% purity. Ideal for reliable API intermediate suppliers seeking scalable production.
Patent CN118005766B reveals novel solid-phase synthesis for Glepaglutide improving purity and yield. Discover cost-effective supply chain solutions for pharmaceutical intermediates.
Patent CN112500453A reveals a novel solid-phase synthesis for Iseganan. Discover how on-resin disulfide oxidation improves purity and enables scalable API production.
Novel unnatural amino acid synthesis improves MAPS polypeptide purity and yield via symmetric branching, offering cost-effective pharma intermediate solutions.
Patent CN115651070B details thioether-bonded H2 Relaxin synthesis. Offers simplified SPPS route, enhanced stability, and cost-effective manufacturing for pharmaceutical partners.
Patent CN109575109B reveals a novel fragment condensation method for Degarelix, offering significant cost reduction and high purity for reliable peptide API supply chains.
Discover the novel hydrazide-based synthesis of Pramlintide (CN111499719B). High-purity API intermediate manufacturing with optimized fragment coupling and scalable oxidation processes.
Novel fragment condensation method reduces racemization. Reliable semaglutide supplier offering cost-effective manufacturing solutions.
Novel solid-phase synthesis of goserelin using CDI activation improves yield and purity. Cost-effective manufacturing for pharmaceutical intermediates.
Patent CN102464702A reveals a high-purity Boc-solid phase synthesis for Leuprorelin Acetate, offering superior environmental safety and supply chain reliability for pharmaceutical manufacturers.